Loading…
Transcranial Alternating Current Stimulation: A Potential Risk for Genetic Generalized Epilepsy Patients (Study Case)
Transcranial alternating current stimulation (tACS) is a re-emergent neuromodulation technique that consists in the external application of oscillating electrical currents that induces changes in cortical excitability. We present the case of a 16-year-old female with pharmaco-resistant juvenile myoc...
Saved in:
Published in: | Frontiers in neurology 2016-11, Vol.7, p.213 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c429t-b92f533ae493ccf716faeb3f49d2ea8515c3b43f2a0f866bb55231f5e0f28d363 |
---|---|
cites | cdi_FETCH-LOGICAL-c429t-b92f533ae493ccf716faeb3f49d2ea8515c3b43f2a0f866bb55231f5e0f28d363 |
container_end_page | |
container_issue | |
container_start_page | 213 |
container_title | Frontiers in neurology |
container_volume | 7 |
creator | San-Juan, Daniel Sarmiento, Carlos Ignacio Hernandez-Ruiz, Axel Elizondo-Zepeda, Ernesto Santos-Vázquez, Gabriel Reyes-Acevedo, Gerardo Zúñiga-Gazcón, Héctor Zamora-Jarquín, Carol Marina |
description | Transcranial alternating current stimulation (tACS) is a re-emergent neuromodulation technique that consists in the external application of oscillating electrical currents that induces changes in cortical excitability. We present the case of a 16-year-old female with pharmaco-resistant juvenile myoclonic epilepsy to 3 antiepileptic's drugs characterized by 4 myoclonic and 20 absence seizures monthly. She received tACS at 1 mA at 3 Hz pulse train during 60 min over Fp1-Fp2 (10-20 EEG international system position) during 4 consecutive days using an Endeavor™ IOM Systems device
(Natus Medical Incorporated, Middleton, WI, USA). At the 1-month follow-up, she reported a 75% increase in seizures frequency (only myoclonic and tonic-clonic events) and developed a 24-h myoclonic status epilepticus that resolved with oral clonazepam and intravenous valproate. At the 2-month follow-up, the patient reported a 15-day seizure-free period. |
doi_str_mv | 10.3389/fneur.2016.00213 |
format | article |
fullrecord | <record><control><sourceid>pubmed_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_27fc10b0e9d64d0384e43e4d2f33fc4f</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_27fc10b0e9d64d0384e43e4d2f33fc4f</doaj_id><sourcerecordid>27965623</sourcerecordid><originalsourceid>FETCH-LOGICAL-c429t-b92f533ae493ccf716faeb3f49d2ea8515c3b43f2a0f866bb55231f5e0f28d363</originalsourceid><addsrcrecordid>eNpVkUFvGyEQhVHVqonS3HuqOLYHu8AAXnqoZFlpEilSoyY9IxYGl3S9a8FuJffXF9tNlHBgRg_eB6NHyHvO5gCN-Rx7nPJcMK7njAkOr8gp11rOhDDq9bP-hJyX8sDqAmNAw1tyIhZGKy3glEz32fXF1y25ji67EXPvxtSv6WrKGfuR3o1pM3VVG_ovdElvh7Gq-8s_UvlN45DpJfY4Jn-o2XXpLwZ6sU0dbsuO3lZnNRT68W6cwo6uXMFP78ib6LqC5__rGfn57eJ-dTW7-X55vVrezLwUZpy1RkQF4FAa8D4uuI4OW4jSBIGuUVx5aCVE4VhstG5bpQTwqJBF0YQ66hm5PnLD4B7sNqeNyzs7uGQPwpDX1uX69Q6tWETPWcvQBC0Dg0aiBJRBRIDoZaysr0fWdmo3GHwdqg77AvrypE-_7Hr4YxUXctGoCmBHgM9DKRnjk5czu0_UHhK1-0TtIdFq-fD8zSfDY37wD0sHoEk</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Transcranial Alternating Current Stimulation: A Potential Risk for Genetic Generalized Epilepsy Patients (Study Case)</title><source>PubMed Central</source><creator>San-Juan, Daniel ; Sarmiento, Carlos Ignacio ; Hernandez-Ruiz, Axel ; Elizondo-Zepeda, Ernesto ; Santos-Vázquez, Gabriel ; Reyes-Acevedo, Gerardo ; Zúñiga-Gazcón, Héctor ; Zamora-Jarquín, Carol Marina</creator><creatorcontrib>San-Juan, Daniel ; Sarmiento, Carlos Ignacio ; Hernandez-Ruiz, Axel ; Elizondo-Zepeda, Ernesto ; Santos-Vázquez, Gabriel ; Reyes-Acevedo, Gerardo ; Zúñiga-Gazcón, Héctor ; Zamora-Jarquín, Carol Marina</creatorcontrib><description>Transcranial alternating current stimulation (tACS) is a re-emergent neuromodulation technique that consists in the external application of oscillating electrical currents that induces changes in cortical excitability. We present the case of a 16-year-old female with pharmaco-resistant juvenile myoclonic epilepsy to 3 antiepileptic's drugs characterized by 4 myoclonic and 20 absence seizures monthly. She received tACS at 1 mA at 3 Hz pulse train during 60 min over Fp1-Fp2 (10-20 EEG international system position) during 4 consecutive days using an Endeavor™ IOM Systems device
(Natus Medical Incorporated, Middleton, WI, USA). At the 1-month follow-up, she reported a 75% increase in seizures frequency (only myoclonic and tonic-clonic events) and developed a 24-h myoclonic status epilepticus that resolved with oral clonazepam and intravenous valproate. At the 2-month follow-up, the patient reported a 15-day seizure-free period.</description><identifier>ISSN: 1664-2295</identifier><identifier>EISSN: 1664-2295</identifier><identifier>DOI: 10.3389/fneur.2016.00213</identifier><identifier>PMID: 27965623</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>adverse events ; generalized epilepsy ; Neuromodulation ; Neuroscience ; Status Epilepticus ; transcranial alternating current stimulation (tACS)</subject><ispartof>Frontiers in neurology, 2016-11, Vol.7, p.213</ispartof><rights>Copyright © 2016 San-Juan, Sarmiento, Hernandez-Ruiz, Elizondo-Zepeda, Santos-Vázquez, Reyes-Acevedo, Zúñiga-Gazcón and Zamora-Jarquín. 2016 San-Juan, Sarmiento, Hernandez-Ruiz, Elizondo-Zepeda, Santos-Vázquez, Reyes-Acevedo, Zúñiga-Gazcón and Zamora-Jarquín</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c429t-b92f533ae493ccf716faeb3f49d2ea8515c3b43f2a0f866bb55231f5e0f28d363</citedby><cites>FETCH-LOGICAL-c429t-b92f533ae493ccf716faeb3f49d2ea8515c3b43f2a0f866bb55231f5e0f28d363</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5124785/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5124785/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27965623$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>San-Juan, Daniel</creatorcontrib><creatorcontrib>Sarmiento, Carlos Ignacio</creatorcontrib><creatorcontrib>Hernandez-Ruiz, Axel</creatorcontrib><creatorcontrib>Elizondo-Zepeda, Ernesto</creatorcontrib><creatorcontrib>Santos-Vázquez, Gabriel</creatorcontrib><creatorcontrib>Reyes-Acevedo, Gerardo</creatorcontrib><creatorcontrib>Zúñiga-Gazcón, Héctor</creatorcontrib><creatorcontrib>Zamora-Jarquín, Carol Marina</creatorcontrib><title>Transcranial Alternating Current Stimulation: A Potential Risk for Genetic Generalized Epilepsy Patients (Study Case)</title><title>Frontiers in neurology</title><addtitle>Front Neurol</addtitle><description>Transcranial alternating current stimulation (tACS) is a re-emergent neuromodulation technique that consists in the external application of oscillating electrical currents that induces changes in cortical excitability. We present the case of a 16-year-old female with pharmaco-resistant juvenile myoclonic epilepsy to 3 antiepileptic's drugs characterized by 4 myoclonic and 20 absence seizures monthly. She received tACS at 1 mA at 3 Hz pulse train during 60 min over Fp1-Fp2 (10-20 EEG international system position) during 4 consecutive days using an Endeavor™ IOM Systems device
(Natus Medical Incorporated, Middleton, WI, USA). At the 1-month follow-up, she reported a 75% increase in seizures frequency (only myoclonic and tonic-clonic events) and developed a 24-h myoclonic status epilepticus that resolved with oral clonazepam and intravenous valproate. At the 2-month follow-up, the patient reported a 15-day seizure-free period.</description><subject>adverse events</subject><subject>generalized epilepsy</subject><subject>Neuromodulation</subject><subject>Neuroscience</subject><subject>Status Epilepticus</subject><subject>transcranial alternating current stimulation (tACS)</subject><issn>1664-2295</issn><issn>1664-2295</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkUFvGyEQhVHVqonS3HuqOLYHu8AAXnqoZFlpEilSoyY9IxYGl3S9a8FuJffXF9tNlHBgRg_eB6NHyHvO5gCN-Rx7nPJcMK7njAkOr8gp11rOhDDq9bP-hJyX8sDqAmNAw1tyIhZGKy3glEz32fXF1y25ji67EXPvxtSv6WrKGfuR3o1pM3VVG_ovdElvh7Gq-8s_UvlN45DpJfY4Jn-o2XXpLwZ6sU0dbsuO3lZnNRT68W6cwo6uXMFP78ib6LqC5__rGfn57eJ-dTW7-X55vVrezLwUZpy1RkQF4FAa8D4uuI4OW4jSBIGuUVx5aCVE4VhstG5bpQTwqJBF0YQ66hm5PnLD4B7sNqeNyzs7uGQPwpDX1uX69Q6tWETPWcvQBC0Dg0aiBJRBRIDoZaysr0fWdmo3GHwdqg77AvrypE-_7Hr4YxUXctGoCmBHgM9DKRnjk5czu0_UHhK1-0TtIdFq-fD8zSfDY37wD0sHoEk</recordid><startdate>20161128</startdate><enddate>20161128</enddate><creator>San-Juan, Daniel</creator><creator>Sarmiento, Carlos Ignacio</creator><creator>Hernandez-Ruiz, Axel</creator><creator>Elizondo-Zepeda, Ernesto</creator><creator>Santos-Vázquez, Gabriel</creator><creator>Reyes-Acevedo, Gerardo</creator><creator>Zúñiga-Gazcón, Héctor</creator><creator>Zamora-Jarquín, Carol Marina</creator><general>Frontiers Media S.A</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20161128</creationdate><title>Transcranial Alternating Current Stimulation: A Potential Risk for Genetic Generalized Epilepsy Patients (Study Case)</title><author>San-Juan, Daniel ; Sarmiento, Carlos Ignacio ; Hernandez-Ruiz, Axel ; Elizondo-Zepeda, Ernesto ; Santos-Vázquez, Gabriel ; Reyes-Acevedo, Gerardo ; Zúñiga-Gazcón, Héctor ; Zamora-Jarquín, Carol Marina</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c429t-b92f533ae493ccf716faeb3f49d2ea8515c3b43f2a0f866bb55231f5e0f28d363</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>adverse events</topic><topic>generalized epilepsy</topic><topic>Neuromodulation</topic><topic>Neuroscience</topic><topic>Status Epilepticus</topic><topic>transcranial alternating current stimulation (tACS)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>San-Juan, Daniel</creatorcontrib><creatorcontrib>Sarmiento, Carlos Ignacio</creatorcontrib><creatorcontrib>Hernandez-Ruiz, Axel</creatorcontrib><creatorcontrib>Elizondo-Zepeda, Ernesto</creatorcontrib><creatorcontrib>Santos-Vázquez, Gabriel</creatorcontrib><creatorcontrib>Reyes-Acevedo, Gerardo</creatorcontrib><creatorcontrib>Zúñiga-Gazcón, Héctor</creatorcontrib><creatorcontrib>Zamora-Jarquín, Carol Marina</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>San-Juan, Daniel</au><au>Sarmiento, Carlos Ignacio</au><au>Hernandez-Ruiz, Axel</au><au>Elizondo-Zepeda, Ernesto</au><au>Santos-Vázquez, Gabriel</au><au>Reyes-Acevedo, Gerardo</au><au>Zúñiga-Gazcón, Héctor</au><au>Zamora-Jarquín, Carol Marina</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Transcranial Alternating Current Stimulation: A Potential Risk for Genetic Generalized Epilepsy Patients (Study Case)</atitle><jtitle>Frontiers in neurology</jtitle><addtitle>Front Neurol</addtitle><date>2016-11-28</date><risdate>2016</risdate><volume>7</volume><spage>213</spage><pages>213-</pages><issn>1664-2295</issn><eissn>1664-2295</eissn><abstract>Transcranial alternating current stimulation (tACS) is a re-emergent neuromodulation technique that consists in the external application of oscillating electrical currents that induces changes in cortical excitability. We present the case of a 16-year-old female with pharmaco-resistant juvenile myoclonic epilepsy to 3 antiepileptic's drugs characterized by 4 myoclonic and 20 absence seizures monthly. She received tACS at 1 mA at 3 Hz pulse train during 60 min over Fp1-Fp2 (10-20 EEG international system position) during 4 consecutive days using an Endeavor™ IOM Systems device
(Natus Medical Incorporated, Middleton, WI, USA). At the 1-month follow-up, she reported a 75% increase in seizures frequency (only myoclonic and tonic-clonic events) and developed a 24-h myoclonic status epilepticus that resolved with oral clonazepam and intravenous valproate. At the 2-month follow-up, the patient reported a 15-day seizure-free period.</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>27965623</pmid><doi>10.3389/fneur.2016.00213</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1664-2295 |
ispartof | Frontiers in neurology, 2016-11, Vol.7, p.213 |
issn | 1664-2295 1664-2295 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_27fc10b0e9d64d0384e43e4d2f33fc4f |
source | PubMed Central |
subjects | adverse events generalized epilepsy Neuromodulation Neuroscience Status Epilepticus transcranial alternating current stimulation (tACS) |
title | Transcranial Alternating Current Stimulation: A Potential Risk for Genetic Generalized Epilepsy Patients (Study Case) |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T00%3A31%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Transcranial%20Alternating%20Current%20Stimulation:%20A%20Potential%20Risk%20for%20Genetic%20Generalized%20Epilepsy%20Patients%20(Study%20Case)&rft.jtitle=Frontiers%20in%20neurology&rft.au=San-Juan,%20Daniel&rft.date=2016-11-28&rft.volume=7&rft.spage=213&rft.pages=213-&rft.issn=1664-2295&rft.eissn=1664-2295&rft_id=info:doi/10.3389/fneur.2016.00213&rft_dat=%3Cpubmed_doaj_%3E27965623%3C/pubmed_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c429t-b92f533ae493ccf716faeb3f49d2ea8515c3b43f2a0f866bb55231f5e0f28d363%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/27965623&rfr_iscdi=true |